And, as per the National Center for Biotechnology Information (NCBI), up to one million cardiac pacemakers are implanted in patients with cardiovascular disorders around the world each year.
Emergen Research has published its latest report titled “Leadless Pacemaker Systems Market, By Product Type (Micra Transcatheter Pacing System, Nanostim Leadless Pacemaker, Others), By Application (Atrial Fibrillation, Sinus Node Dysfunction, Atrioventricular Block, Others), By Technology (Single-chambered, Double-chambered, Subcutaneous ICD Leadless Pacing), By End-use (Hospitals, Ambulatory Surgical Centers, Others), and By Region Forecast to 2028”
Market Dynamics:
The global leadless pacemaker systems market revenue growth is substantially driven by factors such as rising prevalence of cardiovascular diseases worldwide, rapidly growing geriatric population, growing preference for minimally invasive cardiovascular treatment approaches, and technological advancements in cardiac pacemaker systems. According to the World Health Organization, more than 17.9 million people worldwide die from of cardiovascular diseases each year. And, as per the National Center for Biotechnology Information (NCBI), up to one million cardiac pacemakers are implanted in patients with cardiovascular disorders around the world each year.
Click Here to Access Free sample PDF Copy of the Report@ https://www.emergenresearch.com/request-sample/896
Leadless pacemakers are self-contained electrode devices that are significantly smaller than transvenous pacemakers and can be implanted into the right ventricle of the patient’s heart directly. This type of pacemaker eliminates the risks of several complications such as pocket infections, lead dislodgment, hematoma, and lead fracture. Furthermore, growing demand for leadless pacemakers due to their advantages over transvenous pacemakers, increasing availability of favorable healthcare reimbursement policies, rising healthcare expenditure, and rapidly advancing healthcare infrastructure are expected to drive the global market revenue growth.
COVID-19 Impact Analysis:
- Social distancing and restrictions severely disrupted businesses and operations
- Lockdowns caused disruptions in transportation and logistics
- Impacted manufacturing activities and mining operations globally
- Took a toll on economy of various countries
- Caused sudden and drastic downturn in economic activity
- Disrupted agriculture, fisheries, dairy, and other sectors
- Caused loss of employment and financial crisis
- Supply impacts were further compounded owing to reduced disposable income
- Emergence of variants continue to cause concerns and impact normal routines
Micra Transcatheter Pacing System Segment Accounted for Largest Revenue Share in 2020:
Based on product type, the global leadless pacemaker systems market is segmented into micra transcatheter pacing system, nanostim leadless cardiac pacemaker, and others. The micra transcatheter pacing system segment accounted for the largest revenue share in the global market in 2020. Micra transcatheter pacing systems offer right ventricular pacing, sensing, and rate responsiveness, and these pacing systems are implanted into the patient’s body percutaneously using a catheter delivery system.
Looking for Discount [Click on the link] @ https://www.emergenresearch.com/request-discount/896
Atrial Fibrillation Segment to Account for Fastest Revenue CAGR:
Based on application, the global leadless pacemaker systems market is segmented into atrial fibrillation, sinus node dysfunction, atrioventricular block, and others. The atrial fibrillation segment is projected to register the fastest revenue growth rate in the global market over the forecast period. Key factors driving revenue growth of this segment are increasing prevalence of heart diseases worldwide, rising cases of atrial fibrillation, technological advances in cardiac pacemakers, and increasing risks of the condition in people aged above 65 years.
North America Accounted for Largest Revenue Share in 2020:
The North America leadless pacemaker systems market dominated other regional markets in terms of largest revenue share in the global market in 2020. Growing prevalence of cardiovascular disorders, growing demand for leadless cardiac pacemakers due to their numerous advantages over other types of pacemakers, increasing cases of atrial fibrillation, and rising focus on development of more effective and advanced cardiac treatment options are some of the major factors driving the regional market revenue growth.
Major Companies in the Global Leadless Pacemaker Systems Market Include:
- Abbott Laboratories
- Medtronic PLC
- EBR Systems Inc.
- Boston Scientific Corporation
- Biotronik
For the purpose of this report, Emergen Research has segmented the global leadless pacemaker systems market on the basis of product type, application, technology, end-use, and region:
Product Type Outlook (Revenue, USD Billion; 2018-2028)
- Micra Transcatheter Pacing System
- Nanostim Leadless Pacemaker
- Others
Application Outlook (Revenue, USD Billion; 2018-2028)
- Atrioventricular Block
- Sinus Node Dysfunction
- Atrial Fibrillation
- Others
Technology Outlook (Revenue, USD Billion; 2018-2028)
- Single-chambered
- Double-chambered
- Subcutaneous ICD Leadless Pacing
End-use Outlook (Revenue, USD Billion; 2018-2028)
- Hospitals
- Ambulatory Surgical Centers
- Others
Have a look at Report Description and Table of Contents of Market Report@ https://www.emergenresearch.com/industry-report/leadless-pacemaker-systems-market
Region Outlook (Revenue, USD Billion; 2018-2028)
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Spain
- BENELUX
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia Pacific
- Latin America
- Brazil
- Rest of Latin America
- Middle East & Africa
- Saudi Arabia
- U.A.E.
- South Africa
- Turkey
- Rest of Middle East & Africa
Explore Similar Reports offered by Emergen Research:
The global nutrigenomics market size reached USD 389.4 Million in 2020 and is expected to register a CAGR of 16.2% during the forecast period. Market revenue growth is primarily driven by increasing global burden of nutrition-related noncommunicable diseases.
The global Sanger sequencing services market size was significantly robust in 2020 and is expected to register steady revenue CAGR over the forecast period. Increasing advancements in sequencing techniques, benefits of Sanger sequencing, and rising investments to accelerate R&D activities in genomics are key factors expected to drive market revenue growth over the forecast period. In addition, increasing application scope of Sangers sequencing technique has boosted deployment of this procedure and is another key factor expected to further contribute to revenue growth of the market going ahead.
The global whole exome sequencing (WES) market size was significantly robust in 2020 and is expected to register a steady revenue CAGR during the forecast period. Rapid adoption of cutting-edge technologies, and rising awareness regarding whole exome sequencing technology are some key factors expected to drive market revenue growth over the forecast period.
The global health data archiving market size is expected to reach USD 9.28 Billion in 2028 and register a revenue CAGR of 14.1% during the forecast period. Increasing volume of digital data and rapid deployment of cloud-based storage solutions are key factors driving global health data archiving market revenue growth.
The global gel documentation system market size reached USD 291.5 Million in 2020 and is expected to register a revenue CAGR of 3.6% during the forecast period. Major factors driving gel documentation system market revenue growth are rising prevalence of infectious diseases and genetic disorders, and rapid developments and advancements across pharmaceutical and biotechnological industries globally.
About Emergen Research
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com
Visit for More Insights: https://www.emergenresearch.com/insights
Explore Our Custom Intelligence services | Growth Consulting Services